Rhythm Pharmaceuticals buy Guggenheim
Start price
21.10.24
/
50%
€46.40
Target price
21.10.25
€64.45
Performance (%)
95.04%
End price
22.10.25
€90.50
Summary
This prediction ended on 22.10.25 with a price of €90.50. With a performance of 95.04% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | 8.721% | 8.721% | 81.907% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is now covered by analysts at Guggenheim. They set a "buy" rating and a $70.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Rhythm Pharmaceuticals
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
06.08.25
06.08.25
€103.73
06.08.26
06.08.26
21.94%
07:31
07:31
